WHY
STUDY CHAPERONE-MEDIATED PROTEIN FOLDING?
Understanding how
proteins fold in the cell is a central problem in modern biology.
The transformation of the one-dimensional genetic information
into three-dimensional protein structures depends on the accuracy
and efficiency of the process of protein folding and the maintenance
of this correct conformation is essential for protein function
and hence for the life of the cell. While in vitro folding
experiments have shown that the process can occur spontaneously,
it appears that several protein families, generically termed
molecular chaperones, are required for the correct folding
and assembly of proteins in the cell. Despite considerable
progress in the biochemical and biophysical analysis of molecular
chaperones, surprisingly little is known about how protein
folding occurs in vivo, following translation by cytosolic
ribosomes. Progress in this area has been hindered by the
lack of experimental approaches to study the folding intermediates
of newly translated proteins in the complex cellular environment
found in both translation lysates and intact cells. Our research
aim is to examine the chaperone-interactions and folding intermediates
of newly translated polypeptides under physiological conditions.
By emphasizing folding events as they occur at the ribosome
during synthesis of a polypeptide we will be able to understand
the pathways of protein folding in eukaryotic cells and how
this folding is regulated.
The
research we carry out in the laboratory will provide both conceptual
and experimental tools to understand how proteins fold in the
cell. Considering that many folding-related diseases result
from very complex interactions between multiple cellular components,
these tools will prove essential to address mechanistic and
cell biological questions.
Importantly,
recent findings indicating that the cellular accumulation of
incorrectly folded proteins is the molecular basis of many diseases,
including Alzheimer's Disease, Prion Diseases and Huntington
Disease, underscore the importance of understanding the mechanisms
of folding in vivo. Alzheimer's and prion disease appear to
be caused by the generation of a "pathological" conformation
in the newly translated protein that would otherwise fold to
a normal conformation that does not produce the disease. In
some model systems, molecular chaperones appear to play a role
in this conformational change. Thus, developing approaches to
study protein folding under physiological conditions is essential
to understand how folding defects can lead to disease.